{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:44:43Z","timestamp":1771487083281,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:00:00Z","timestamp":1728345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V112C-129;V113C-097"],"award-info":[{"award-number":["V112C-129;V113C-097"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-075-064-MY2;110-2314-B-075-081"],"award-info":[{"award-number":["111-2314-B-075-064-MY2;110-2314-B-075-081"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2314-B-075-004;110-2314-B-075-035-MY2;109-2314-B-075-002"],"award-info":[{"award-number":["113-2314-B-075-004;110-2314-B-075-035-MY2;109-2314-B-075-002"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2321-B-A49-004; 111-2314-B-075-086-MY3; 111-2321-B-A49-011; 112-2321-B-075-007"],"award-info":[{"award-number":["111-2321-B-A49-004; 111-2314-B-075-086-MY3; 111-2321-B-A49-011; 112-2321-B-075-007"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education (MOE) in Taiwan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"DOI":"10.1186\/s10194-024-01862-8","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T09:01:46Z","timestamp":1728378106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pre-cluster symptoms in a Taiwanese cohort of cluster headache: symptom profiles and clinical predictions"],"prefix":"10.1186","volume":"25","author":[{"given":"Jr-Wei","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Pin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Yi","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Shiuan","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ta","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chun","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuu-Jiun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,8]]},"reference":[{"issue":"1","key":"1862_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s10194-022-01427-7","volume":"23","author":"AS Petersen","year":"2022","unstructured":"Petersen AS et al (2022) The economic and personal burden of cluster headache: a controlled cross-sectional study. J Headache Pain 23(1):58","journal-title":"J Headache Pain"},{"issue":"6","key":"1862_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1136\/practneurol-2018-002124","volume":"19","author":"YW Diana","year":"2019","unstructured":"Diana YW, Modar K, Peter JG (2019) Managing cluster headache. Pract Neurol 19(6):521","journal-title":"Pract Neurol"},{"key":"1862_CR3","doi-asserted-by":"publisher","first-page":"18006","DOI":"10.1038\/nrdp.2018.6","volume":"4","author":"A May","year":"2018","unstructured":"May A et al (2018) Cluster headache. Nat Rev Dis Primers 4:18006","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"1862_CR4","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/head.13567","volume":"59","author":"IF de Coo","year":"2019","unstructured":"de Coo IF et al (2019) Chronobiology and Sleep in Cluster Headache. Headache 59(7):1032\u20131041","journal-title":"Headache"},{"issue":"10","key":"1862_CR5","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1177\/0333102419845660","volume":"39","author":"M Ji Lee","year":"2019","unstructured":"Ji Lee M et al (2019) Increased suicidality in patients with cluster headache. Cephalalgia 39(10):1249\u20131256","journal-title":"Cephalalgia"},{"issue":"3","key":"1862_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/0333102412469738","volume":"33","author":"JF Liang","year":"2013","unstructured":"Liang JF et al (2013) Cluster headache is associated with an increased risk of depression: a nationwide population-based cohort study. Cephalalgia 33(3):182\u2013189","journal-title":"Cephalalgia"},{"issue":"1","key":"1862_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1474-4422(17)30405-2","volume":"17","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, May A (2018) Diagnosis, pathophysiology, and management of cluster headache. Lancet Neurol 17(1):75\u201383","journal-title":"Lancet Neurol"},{"issue":"7","key":"1862_CR8","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/0333102421989255","volume":"41","author":"AS Pedersen","year":"2021","unstructured":"Pedersen AS et al (2021) Prevalence of pre-cluster symptoms in episodic cluster headache: is it possible to predict an upcoming bout? Cephalalgia 41(7):799\u2013809","journal-title":"Cephalalgia"},{"issue":"6","key":"1862_CR9","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1177\/0333102417726498","volume":"38","author":"A Snoer","year":"2018","unstructured":"Snoer A et al (2018) Pre-attack signs and symptoms in cluster headache: characteristics and time profile. Cephalalgia 38(6):1128\u20131137","journal-title":"Cephalalgia"},{"issue":"9","key":"1862_CR10","doi-asserted-by":"publisher","first-page":"e822","DOI":"10.1212\/01.wnl.0000542491.92981.03","volume":"91","author":"A Snoer","year":"2018","unstructured":"Snoer A et al (2018) Cluster headache beyond the pain phase: a prospective study of 500 attacks. Neurology 91(9):e822\u2013e831","journal-title":"Neurology"},{"issue":"7","key":"1862_CR11","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1177\/03331024211067784","volume":"42","author":"S Cho","year":"2022","unstructured":"Cho S et al (2022) Characteristics of pre-cluster symptoms in cluster headache: a cross-sectional multicentre study. Cephalalgia 42(7):570\u2013578","journal-title":"Cephalalgia"},{"issue":"1","key":"1862_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s10194-022-01459-z","volume":"23","author":"K Li","year":"2022","unstructured":"Li K et al (2022) Pre-attack and pre-episode symptoms in cluster headache: a multicenter cross-sectional study of 327 Chinese patients. J Headache Pain 23(1):92","journal-title":"J Headache Pain"},{"key":"1862_CR13","doi-asserted-by":"crossref","unstructured":"Blau JN, Engel HO (1998) Premonitory and prodromal symptoms in cluster headache. Cephalalgia, 18(2): p. 91\u2009\u2013\u20093; discussion 71\u2009\u2013\u20092.","DOI":"10.1046\/j.1468-2982.1998.1802091.x"},{"issue":"10419","key":"1862_CR14","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/S0140-6736(23)01683-5","volume":"402","author":"DW Dodick","year":"2023","unstructured":"Dodick DW et al (2023) Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA. Lancet 402(10419):2307\u20132316","journal-title":"Lancet"},{"issue":"2","key":"1862_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/brain\/awaa388","volume":"144","author":"AR Tso","year":"2021","unstructured":"Tso AR et al (2021) Machine phenotyping of cluster headache and its response to verapamil. Brain 144(2):655\u2013664","journal-title":"Brain"},{"key":"1862_CR16","first-page":"254","volume":"31","author":"F-C Yang","year":"2022","unstructured":"Yang F-C, Tsai C-L, Lin G-Y; Treatment Guidelines Subcommittee of the Taiwan Headache Society (2022) 2022 Taiwan Guidelines for Acute and Preventive Treatment of Cluster Headaches. Acta Neurol Taiwan 31(4):254\u2013273","journal-title":"Acta Neurol Taiwan"},{"key":"1862_CR17","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","DOI":"10.1177\/0333102417738202"},{"issue":"7","key":"1862_CR18","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1177\/0333102417731773","volume":"38","author":"A Steinberg","year":"2017","unstructured":"Steinberg A et al (2017) Cluster headache \u2013 clinical pattern and a new severity scale in a Swedish cohort. Cephalalgia 38(7):1286\u20131295","journal-title":"Cephalalgia"},{"issue":"7","key":"1862_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamaneurol.2018.1049","volume":"75","author":"MJ Burish","year":"2018","unstructured":"Burish MJ, Chen Z, Yoo SH (2018) Cluster headache is in Part a disorder of the Circadian System. JAMA Neurol 75(7):783\u2013784","journal-title":"JAMA Neurol"},{"issue":"22","key":"1862_CR20","doi-asserted-by":"publisher","first-page":"e2224","DOI":"10.1212\/WNL.0000000000207240","volume":"100","author":"B Benkli","year":"2023","unstructured":"Benkli B et al (2023) Circadian features of Cluster Headache and Migraine: a systematic review, Meta-analysis, and genetic analysis. Neurology 100(22):e2224\u2013e2236","journal-title":"Neurology"},{"issue":"Pt 1","key":"1862_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/brain\/awt320","volume":"137","author":"FH Maniyar","year":"2014","unstructured":"Maniyar FH et al (2014) Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain 137(Pt 1):232\u2013241","journal-title":"Brain"},{"issue":"12","key":"1862_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41582-018-0098-4","volume":"14","author":"N Karsan","year":"2018","unstructured":"Karsan N, Goadsby PJ (2018) Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol 14(12):699\u2013710","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1862_CR23","doi-asserted-by":"publisher","first-page":"033310242211282","DOI":"10.1177\/03331024221128287","volume":"43","author":"M-LK S\u00f8borg","year":"2023","unstructured":"S\u00f8borg M-LK et al (2023) Transition of cluster headache phenotype: an interview-based study. Cephalalgia 43(1):03331024221128287","journal-title":"Cephalalgia"},{"issue":"8","key":"1862_CR24","doi-asserted-by":"publisher","first-page":"333102423119680","DOI":"10.1177\/03331024231196808","volume":"43","author":"KP Peng","year":"2023","unstructured":"Peng KP, Burish MJ (2023) Management of cluster headache: treatments and their mechanisms. Cephalalgia 43(8):3331024231196808","journal-title":"Cephalalgia"},{"issue":"1","key":"1862_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1474-4422(20)30363-X","volume":"20","author":"M Obermann","year":"2021","unstructured":"Obermann M et al (2021) Safety and efficacy of prednisone versus placebo in short-term prevention of episodic cluster headache: a multicentre, double-blind, randomised controlled trial. Lancet Neurol 20(1):29\u201337","journal-title":"Lancet Neurol"},{"issue":"14","key":"1862_CR26","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1177\/03331024221120266","volume":"42","author":"J Schoenen","year":"2022","unstructured":"Schoenen J et al (2022) Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache. Cephalalgia 42(14):1450\u20131466","journal-title":"Cephalalgia"},{"issue":"10","key":"1862_CR27","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1177\/0333102420923646","volume":"40","author":"KP Peng","year":"2020","unstructured":"Peng KP, Takizawa T, Lee MJ (2020) Cluster headache in Asian populations: similarities, disparities, and a narrative review of the mechanisms of the chronic subtype. Cephalalgia 40(10):1104\u20131112","journal-title":"Cephalalgia"},{"issue":"14","key":"1862_CR28","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1177\/0333102419851815","volume":"39","author":"WC Naber","year":"2019","unstructured":"Naber WC et al (2019) The biological clock in cluster headache: a review and hypothesis. Cephalalgia 39(14):1855\u20131866","journal-title":"Cephalalgia"},{"issue":"12","key":"1862_CR29","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/pm\/pnz070","volume":"20","author":"A Gil-Mart\u00ednez","year":"2019","unstructured":"Gil-Mart\u00ednez A et al (2019) Hyperalgesia and Central Sensitization Signs in patients with cluster headache: a cross-sectional study. Pain Med 20(12):2562\u20132570","journal-title":"Pain Med"},{"issue":"1","key":"1862_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s10194-022-01504-x","volume":"23","author":"MA-M Al-Karagholi","year":"2022","unstructured":"Al-Karagholi MA-M et al (2022) Debate: are cluster headache and migraine distinct headache disorders? J Headache Pain 23(1):151","journal-title":"J Headache Pain"},{"issue":"1","key":"1862_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s10194-022-01510-z","volume":"23","author":"AK Eigenbrodt","year":"2022","unstructured":"Eigenbrodt AK et al (2022) Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency. J Headache Pain 23(1):140","journal-title":"J Headache Pain"},{"issue":"13","key":"1862_CR32","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1177\/0333102419867280","volume":"39","author":"A May","year":"2019","unstructured":"May A, Burstein R (2019) Hypothalamic regulation of headache and migraine. Cephalalgia 39(13):1710\u20131719","journal-title":"Cephalalgia"},{"key":"1862_CR33","doi-asserted-by":"crossref","unstructured":"Peter J Goadsby, Arne May (1999) PET demonstration of hypothalamic activation in cluster headache. Neurology. 52(7): p. 1522","DOI":"10.1212\/WNL.52.7.1522"},{"key":"1862_CR34","doi-asserted-by":"crossref","unstructured":"Petersen AS et al (2019) Verapamil and Cluster Headache: Still a Mystery. A Narrative Review of Efficacy, Mechanisms and Perspectives. Headache: The Journal of Head and Face Pain, 59(8): pp. 1198\u20131211","DOI":"10.1111\/head.13603"},{"issue":"6","key":"1862_CR35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/07420528.2021.1892127","volume":"38","author":"MJ Burish","year":"2021","unstructured":"Burish MJ et al (2021) The first-line cluster headache medication verapamil alters the circadian period and elicits sex-specific sleep changes in mice. Chronobiol Int 38(6):839\u2013850","journal-title":"Chronobiol Int"},{"issue":"1","key":"1862_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1526-4610.2008.01298.x","volume":"49","author":"P Tfelt-Hansen","year":"2009","unstructured":"Tfelt-Hansen P, Tfelt-Hansen J (2009) Verapamil for cluster headache. Clinical pharmacology and possible mode of action. Headache 49(1):117\u2013125","journal-title":"Headache"},{"issue":"3","key":"1862_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/mol.110.069492","volume":"79","author":"P Bergson","year":"2011","unstructured":"Bergson P et al (2011) Verapamil block of T-type calcium channels. Mol Pharmacol 79(3):411\u2013419","journal-title":"Mol Pharmacol"},{"issue":"10","key":"1862_CR38","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/mp.2016.86","volume":"21","author":"A Cipriani","year":"2016","unstructured":"Cipriani A et al (2016) A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development. Mol Psychiatry 21(10):1324\u20131332","journal-title":"Mol Psychiatry"},{"issue":"14","key":"1862_CR39","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1177\/0333102418769955","volume":"38","author":"M Barloese","year":"2018","unstructured":"Barloese M et al (2018) Chronorisk in Cluster headache: a tool for individualised therapy? Cephalalgia 38(14):2058\u20132067","journal-title":"Cephalalgia"},{"issue":"7","key":"1862_CR40","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1046\/j.1468-2982.2003.00531.x","volume":"23","author":"AI Nilsson Remahl","year":"2003","unstructured":"Nilsson Remahl AI et al (2003) Placebo response in cluster headache trials: a review. Cephalalgia 23(7):504\u2013510","journal-title":"Cephalalgia"},{"issue":"12","key":"1862_CR41","doi-asserted-by":"publisher","first-page":"033310242312183","DOI":"10.1177\/03331024231218392","volume":"43","author":"H Basedau","year":"2023","unstructured":"Basedau H et al (2023) Placebo and nocebo in the treatment of migraine: how much does real world effectiveness depend on contextual effects? Cephalalgia 43(12):03331024231218392","journal-title":"Cephalalgia"},{"issue":"3","key":"1862_CR42","doi-asserted-by":"publisher","first-page":"033310242312261","DOI":"10.1177\/03331024231226181","volume":"44","author":"R Lamas P\u00e9rez","year":"2024","unstructured":"Lamas P\u00e9rez R, Mill\u00e1n-V\u00e1zquez M, Gonz\u00e1lez-Oria C (2024) Efficacy and safety of galcanezumab as chronic cluster headache preventive treatment under real world conditions: observational prospective study. Cephalalgia 44(3):03331024231226181","journal-title":"Cephalalgia"},{"issue":"10","key":"1862_CR43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/head.14404","volume":"62","author":"JA Membrilla","year":"2022","unstructured":"Membrilla JA et al (2022) Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative review. Headache: J Head Face Pain 62(10):1395\u20131405","journal-title":"Headache: J Head Face Pain"},{"issue":"1","key":"1862_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s10194-023-01661-7","volume":"24","author":"Y Hong","year":"2023","unstructured":"Hong Y et al (2023) Preventive therapy with galcanezumab for two consecutive cluster bouts in patients with episodic cluster headache: an observational multicenter study. J Headache Pain 24(1):136","journal-title":"J Headache Pain"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01862-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-024-01862-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-024-01862-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T09:02:02Z","timestamp":1728378122000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-024-01862-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1862"],"URL":"https:\/\/doi.org\/10.1186\/s10194-024-01862-8","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,8]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this study was approved by the Institutional Review Board of the Taipei Veterans General Hospital (2021-04-008CC). All the participants provided written consent before the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors authorize the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JWW served as the Chair of Communication Committee of International Headache Society and has received travel reimbursement and honoraria from the American Academy of Neurology, International Headache Society, and Taiwan Headache Society. He has received honoraria (as a speaker) from Biogen-Idec, Eli Lilly, and Hoan Pharmaceuticals. Additionally, JWW and STC received research grants from the Taiwan National Science and Technology Council and Taipei Veterans General Hospital. CCC has served as a consultant for Satsuma and eNeura. She receives a research grant from the American Heart Association with funds paid to her institution. Shuu-Jiun Wang has received honoraria as a moderator from AbbVie, Biogen, Eli-Lilly, Hava Biopharma, and Pfizer; has received consulting fees from AbbVie, Eli-Lilly Taiwan, Percept Co., and Pfizer Taiwan; and has been the principal investigator in trials sponsored by Eli-Lilly, Lundbeck, and Novartis. He has received research grants from the Taiwan branches of Eli Lilly, Novartis, and Orient Europharma.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}